Category Archives: Neurology

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/dsmzkg/austria_neurology) has announced the addition of GlobalData's new report "Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, "Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the Austria Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Key Topics Covered:

1 List of Tables and Figures

2 Introduction

3 Neurology Devices In Austria

4 CSF Management In Austria

5 Interventional Neurology In Austria

6 Neurological Diagnostic Equipment In Austria

Here is the original post:
Research and Markets: Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/759qr2/australia_neurolog) has announced the addition of GlobalData's new report "Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Australia Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Key Topics Covered:

1 List of Tables and Figures

2 Introduction

3 Neurology Devices In Australia

4 CSF Management In Australia

5 Interventional Neurology In Australia

6 Neurological Diagnostic Equipment In Australia

See more here:
Research and Markets: Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/pzllkj/italy_neurology_de) has announced the addition of GlobalData's new report "Italy Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Italy Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Italy Neurology Devices market.

The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories:

- CSF Management

- Interventional Neurology

- Neurological Diagnostic Equipment

- Neurostimulation Devices

- Neurosurgical Products and Radiosurgery

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

View original post here:
Research and Markets: Italy Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

Newswise PHILADELPHIA Frances E. Jensen, MD, has been named Chair of the Department of Neurology in the Perelman School of Medicine at the University of Pennsylvania. She comes to Penn Medicine from Boston, where she is currently Professor of Neurology at Harvard Medical School and a senior neurologist at both Brigham and Womens Hospital and Childrens Hospital, Boston. Starting August 13, Jensen will become the 11th chair to lead Penns Department of Neurology, the oldest neurology department in the United States, founded by Dr. Horatio Wood in 1871.

I am confident that Dr. Jensen, with her range of research strengths, teaching skills, and clinical dedication, is the perfect person to lead the Department into the future and help to shape our many initiatives in neuroscience, said J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System. Dr. Jensen is a dedicated and inspiring teacher and mentor, and is highly regarded for her translational research and studies of the age-specific mechanisms of diseases of the brain across the lifespan.

Dr. Jensens research has focused on investigating pathophysiological mechanisms of epilepsy as well as secondary effects on synaptic plasticity. She has been exploring age-dependent differences in such mechanisms, with special attention to the interactions among brain development, excitotoxic brain injury, epilepsy, and cognition.

Most recently, supported by a five-year Directors Pioneer Award from the (NIH), Dr. Jensen has been investigating connections between epilepsy and autism, examining how seizures in early life alter neuronal networks in the developing brain to cause cognitive disorders such as learning deficits, neuropsychiatric symptoms, and autism. As she told Nature Medicine last year, We are finding connections between previously assumed unrelated disorders that we could never have imagined.

Dr. Jensen is the sponsor of an FDA-approved Investigational New Drug (IND) for a continuing multi-center clinical trial of a novel therapy for neonatal seizures, based on basic research in her laboratory.

After graduating cum laude from Smith College with an A.B. degree in neuropsychology, Dr. Jensen received her medical degree from Cornell University Medical College. She took her residency in internal medicine at Brigham and Womens Hospital and was Chief Resident in neurology at The Harvard Longwood Neurology Training Program. Dr. Jensen was also a clinical fellow and an instructor in neurology at Harvard Medical School. She became an Assistant Professor of Neurology in 1992, Associate Professor in 1998, and Professor in 2007.

She serves as Director of Translational Neuroscience at Childrens Hospital and is a senior neurologist at both Brigham and Womens Hospital and Childrens Hospital. She is also active in education and mentoring programs related to translational medicine at the Harvard Clinical and Translational Science Center.

Dr. Jensen is the author of more than 100 manuscripts. She is a Fellow of the American College of Physicians, a member of the editorial board of Annals of Neurology, and a reviewing editor for the Journal of Neuroscience. In addition to the Directors Pioneer Award, NIH has awarded her a Physician Scientist Award and a First Independent Research Support and Transition (FIRST) Award. Dr. Jensen is a Council Member of the Society for Neuroscience and is currently serving as President of the American Epilepsy Society. She also served as Chair of the American Epilepsy Society Annual Meeting Committee and Council on Education and oversaw the successful process of accreditation by the ACCME (Accreditation Council for Continuing Medical Education). In 2008, she received the American Epilepsy Society Research Recognition Award for Basic Science. She has served on multiple review and council positions in private foundations and National Institutes of Health. Dr. Jensen has also been active in community service and media: she has been a visiting teacher at local schools and has been an expert commentator on such programs as The Today Show, 60 Minutes, National Public Radios Morning Edition, and Good Morning America.

# # #

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

See original here:
Frances E. Jensen, MD, Named Chair of the Department of Neurology

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/j6vkjm/finland_neurology) has announced the addition of Global Markets Direct's new report "Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

This new report by Global Markets Direct provides key market data on the Finland Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Finland Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Natus Medical Incorporated, Cadwell Laboratories, Inc., Stryker Corporation, B. Braun Melsungen AG and others.

Go here to see the original:
Research and Markets: Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/6kkfzl/russian_federation) has announced the addition of GlobalData's new report "Russian Federation Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Russian Federation Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Russian Federation Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Russian Federation Neurology Devices market.

Companies Mentioned

- Medtronic, Inc.

Go here to see the original:
Research and Markets: Russian Federation Neurology Devices Market Outlook to 2018 - Interventional Neurology ...